ENTRY       D04612                      Drug
NAME        Iratumumab (USAN)
EFFICACY    Antineoplastic, Anti-CD30 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of relapsed or refractory CD30 positive lymphoma including Hodgkin's disease
TARGET      TNFRSF8 (CD30) [HSA:943] [KO:K05145]
  PATHWAY   hsa04060(943)  Cytokine-cytokine receptor interaction
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Tumor necrosis factor receptors
                TNFRSF8 (CD30)
                 D04612  Iratumumab (USAN)
DBLINKS     CAS: 640735-09-7
            PubChem: 47206456
///
